| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/02/2010 | CA2507923C Tetracyclic 3-substituted indoles having serotonin receptor affinity |
| 02/02/2010 | CA2494583C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 02/02/2010 | CA2494176C Intermediates in producing phenoxyacetic acid derivatives and method of using the same |
| 02/02/2010 | CA2485685C Calcium receptor modulating agents |
| 02/02/2010 | CA2479494C Compositions and methods associated with pro5725 and its use for the diagnosis of lung and colon tumor |
| 02/02/2010 | CA2477756C Modified phosphocalcic compound, injectable composition containing same |
| 02/02/2010 | CA2465090C Polymeric thiol-linked prodrugs employing benzyl elimination systems |
| 02/02/2010 | CA2460306C Stable and taste masked pharmaceutical dosage form using porous apatite grains |
| 02/02/2010 | CA2454830C Substituted urea neuropeptide y y5 receptor antagonists |
| 02/02/2010 | CA2442478C Use of group i mglur antagonists in the treatment of fragile x syndrome, autism, mental retardation |
| 02/02/2010 | CA2436752C Bifidobacteria and preparations containing them |
| 02/02/2010 | CA2430562C Dna methyl transferase inhibitors |
| 02/02/2010 | CA2426043C Modulating angiogenesis |
| 02/02/2010 | CA2424186C Antimicrobial compositions formulated for use in cold temperature conditions and methods of use thereof |
| 02/02/2010 | CA2418868C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 02/02/2010 | CA2410305C Preparations comprising combinations of enzyme inhibitors, and the use thereof |
| 02/02/2010 | CA2407428C Hydantoin-containing glucokinase activators |
| 02/02/2010 | CA2401832C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 02/02/2010 | CA2396158C Dipeptide nitrile cathepsin k inhibitors |
| 02/02/2010 | CA2390858C N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa |
| 02/02/2010 | CA2387958C Method of preparing valproic acid compounds |
| 02/02/2010 | CA2383412C Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 02/02/2010 | CA2360228C Treatment of tumor metastases and cancer |
| 02/02/2010 | CA2358581C Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 02/02/2010 | CA2357459C Method for improving bone mineralization |
| 02/02/2010 | CA2333963C Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds |
| 02/02/2010 | CA2324418C Novel opiate compounds, methods of making and methods of use |
| 02/02/2010 | CA2321819C Xylitol compositions for treating upper respiratory conditions |
| 02/02/2010 | CA2316172C Indole derivatives as inhibitors of factor xa |
| 02/02/2010 | CA2315205C Substituted 2-aryl-4-amino-quinazolines, methods for the prodution ans use thereof as medicaments |
| 02/02/2010 | CA2294809C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 02/02/2010 | CA2257973C T cell antigen receptor peptides |
| 02/02/2010 | CA2230885C Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 02/02/2010 | CA2196286C Parallel selex |
| 02/02/2010 | CA2180425C Purified primate ctla-8 antigens and related reagents |
| 02/02/2010 | CA2160898C Alimentative infusion liquids for administration through peripheral vein |
| 02/01/2010 | CA2638176A1 Oligonucleotide and use thereof |
| 01/31/2010 | CA2674011A1 Pharmaceutical compounds |
| 01/31/2010 | CA2674006A1 Microemulsions |
| 01/28/2010 | WO2010011975A1 Oxymatrine compositions and use thereof for treating and preventing chronic infectious diseases |
| 01/28/2010 | WO2010011959A1 Antiviral compounds |
| 01/28/2010 | WO2010011926A2 A novel betaine cocrystal of epalrestat |
| 01/28/2010 | WO2010011922A2 Novel crystalline salts of epalrestat |
| 01/28/2010 | WO2010011917A1 SEH AND 11β-HSD1 DUAL INHIBITORS |
| 01/28/2010 | WO2010011914A1 Trpv4 antagonists |
| 01/28/2010 | WO2010011912A1 Trpv4 antagonists |
| 01/28/2010 | WO2010011895A1 Enhancement of sirna silencing activity using universal bases or mismatches in the sense strand |
| 01/28/2010 | WO2010011879A2 Methods and compositions for treating and preventing autoimmune diseases |
| 01/28/2010 | WO2010011868A2 Pyridine sulfonamide modulators of endothelin-a-receptor |
| 01/28/2010 | WO2010011864A2 Alpha-helix mimetic with functionalized pyridazine |
| 01/28/2010 | WO2010011857A2 Parenteral administration of a glucosamine |
| 01/28/2010 | WO2010011856A2 Stereospecificity of methylsulfinyl reduction |
| 01/28/2010 | WO2010011853A2 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 01/28/2010 | WO2010011845A2 Methods of preventing or treating viral infection or reactivation after latency in a host using inhibitors of the lsd1 protein |
| 01/28/2010 | WO2010011837A1 Fused heterocyclic compounds useful as kinase modulators |
| 01/28/2010 | WO2010011836A2 Treating various disorders with 7,8-dihydroxyflavone and derivatives thereof |
| 01/28/2010 | WO2010011824A1 Novel xanthine compounds |
| 01/28/2010 | WO2010011821A2 Dual-acting antihypertensive agents |
| 01/28/2010 | WO2010011819A1 Chemical compounds |
| 01/28/2010 | WO2010011818A1 Chemical compounds |
| 01/28/2010 | WO2010011816A1 Chemical compounds |
| 01/28/2010 | WO2010011815A1 Chemical compounds |
| 01/28/2010 | WO2010011814A1 Chemical compounds |
| 01/28/2010 | WO2010011813A1 Complex of trospium and pharmaceutical compositions thereof |
| 01/28/2010 | WO2010011812A1 Chemical compounds |
| 01/28/2010 | WO2010011811A2 3-(phenoxyphenylmethyl)pyrrolidine compounds |
| 01/28/2010 | WO2010011782A1 Monocyclic cyanoenones and methods of use thereof |
| 01/28/2010 | WO2010011772A2 Tri-cyclic pyrazolopyridine kinase inhibitors |
| 01/28/2010 | WO2010011768A1 Tri-cyclic pyrazolopyridine kinase inhibitors |
| 01/28/2010 | WO2010011762A1 Pyrazolopyridine kinase inhibitors |
| 01/28/2010 | WO2010011756A1 Pyrazolopyridine kinase inhibitors |
| 01/28/2010 | WO2010011700A2 Treatment of cancers characterized by chromosomal rearrangement of the nut gene |
| 01/28/2010 | WO2010011686A2 Amides as inhibitors of human secreted phospholipase a2 |
| 01/28/2010 | WO2010011666A2 Indoline scaffold shp-2 inhibitors and cancer treatment method |
| 01/28/2010 | WO2010011662A1 Taxane compounds for treating eye disease |
| 01/28/2010 | WO2010011657A1 Bicyclic heterocycle derivatives as histamine h3 receptor antagonists |
| 01/28/2010 | WO2010011653A1 Tricyclic heterocycle derivatives as histamine h3 antagonists |
| 01/28/2010 | WO2010011650A1 Stable water-based topical pharmaceutical creams and methods of making and using same |
| 01/28/2010 | WO2010011630A1 Series of skin-whitening (lightening) compounds |
| 01/28/2010 | WO2010011626A2 Pyridinyl modulators of ϒ-secretase |
| 01/28/2010 | WO2010011620A1 4-phenoxy-6-aryl-1h-pyrazolo[3,4-d]pyrimidine and n-aryl-6-aryl-1h-pyrazolo[3,4-d]pyrimidin-4-amine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 01/28/2010 | WO2010011619A1 Large substituent, non-phenolic amine opioids |
| 01/28/2010 | WO2010011605A2 Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders |
| 01/28/2010 | WO2010011599A2 Pimethixene derivatives for promoting bone growth |
| 01/28/2010 | WO2010011581A2 Polysaccharides extract from dendrobium for treating allergic diseases |
| 01/28/2010 | WO2010011570A1 Adamantyl diamide derivatives and uses of same |
| 01/28/2010 | WO2010011548A1 Novel substituted sulfamide derivatives |
| 01/28/2010 | WO2010011546A2 Acyclic compounds having 5-ht6 receptor affinity |
| 01/28/2010 | WO2010011541A2 Topical anti-inflammatory combination |
| 01/28/2010 | WO2010011538A1 Amidophenoxyindazoles useful as inhibitors of c-met |
| 01/28/2010 | WO2010011537A1 Inhibitors of the plasmodial surface anion channel as antimalarials |
| 01/28/2010 | WO2010011522A1 High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms |
| 01/28/2010 | WO2010011375A2 Inhibitors of janus kinases |
| 01/28/2010 | WO2010011349A2 Pyrimidine-2,4-diamine jak2 kinase inhibiting anti-inflammation use |
| 01/28/2010 | WO2010011346A1 Rnai constructs and uses therof |
| 01/28/2010 | WO2010011325A2 Synthesis and utilization of small molecules for the treatment of inflammation associated with interleukin-1 signaling |
| 01/28/2010 | WO2010011318A2 Activatiqn of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival |
| 01/28/2010 | WO2010011316A1 SUBSTITUTED 1,2,3,4- TETRAHYDROCYCLOPENTA[b]INDOL-3-YL) ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS |
| 01/28/2010 | WO2010011314A1 Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1 |
| 01/28/2010 | WO2010011312A1 Universal methylation profiling methods |